TVTX Historical Earnings image   This TVTX historical earnings page last updated 8/8/2022
TVTX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/4/20220.05B
Q1 20225/5/20220.05B
Q4 20212/24/20220.06B
Q3 202110/28/20210.07B
Q2 20217/29/20210.05B
Q1 20215/6/20210.05B
Q4 20203/1/20210.05B
Q3 202011/5/20200.05B
Q2 20207/30/20200.05B
Q1 20205/11/20200.05B
Q4 20192/24/20200.05B
Q3 201910/30/20190.04B
Q2 20198/6/20190.04B
Q1 20195/7/20190.04B
Q4 20182/26/201943.77M
Q3 201811/1/201840.71M
Q2 20187/26/201841.34M
Q1 20185/1/201838.43M
Q4 20172/27/201842.18M
Q3 201711/7/201740.34M
Q2 20178/9/201738.80M
Q1 20175/4/201733.62M
Q4 20163/1/201737.33M
Q3 201611/3/201633.95M
Q2 20168/4/201633.31M
Q1 20165/3/201629.01M
Q4 20152/25/201630.45M
Q3 201511/3/201528.00M
Q2 20158/4/201524.07M
Q1 20155/11/201517.37M
Q4 20143/5/201514.08M
Q3 201411/13/20148.30M
Q2 20148/12/20145.74M
Q1 20145/14/201430000
TVTX Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20228/4/2022-0.650
Q1 20225/5/2022-0.820
Q4 20212/24/2022-0.610
Q3 202110/28/2021-0.130
Q2 20217/29/2021-0.390
Q1 20215/6/2021-0.550
Q4 20203/1/2021-0.480
Q3 202011/5/2020-0.110
Q2 20207/30/2020-0.220
Q1 20205/11/2020-0.200
Q4 20192/24/2020-0.700
Q3 201910/30/2019-0.660
Q2 20198/6/2019-0.580
Q1 20195/7/2019-0.630
Q4 20182/26/2019-0.21
Q3 201811/1/2018-0.68
Q2 20187/26/2018-0.25
Q1 20185/1/2018-0.14
Q4 20172/27/20180.07
Q3 201711/7/2017-0.46
Q2 20178/9/20170.03
Q1 20175/4/20170.01
Q4 20163/1/20170
Q3 201611/3/2016-0.09
Q2 20168/4/20160.07
Q1 20165/3/20160.14
Q4 20152/25/20160.07
Q3 201511/3/2015-0.04
Q2 20158/4/2015-0.4
Q1 20155/11/2015-0.04
Q4 20143/5/2015-0.36
Q3 201411/13/2014-0.53
Q2 20148/12/2014-0.52
Q1 20145/14/20143.03
Quotes delayed 20 minutes

Email EnvelopeFree TVTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Travere Therapeutics (TVTX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

TVTY Historical Earnings
TWST Historical Earnings
TXG Historical Earnings
TXMD Historical Earnings
TYME Historical Earnings
TYRA Historical Earnings
UBX Historical Earnings
UFPT Historical Earnings
UHS Historical Earnings
UNCY Historical Earnings
What was the record high TVTX historical earnings result?
In terms of earnings or revenue, what is the best TVTX historical earnings result that Travere Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest TVTX historical earnings result was set in Q1 2014, when Travere Therapeutics posted results of 3.03/share. The most successful revenue quarter within our data set was Q3 2021 when Travere Therapeutics reported revenue of 0.07B.

What was the lowest Travere Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest TVTX has reported, and when?

✔️Accepted answer: Within our data set, the lowest TVTX historical earnings result was set in Q1 2022, when Travere Therapeutics posted results of -0.820/share. The smallest revenue quarter within our data set was Q1 2014 when Travere Therapeutics reported revenue of 30000.

On this page we presented the TVTX historical earnings date information for Travere Therapeutics. Reviewing that TVTX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2014, when TVTX posted adjusted EPS of 3.03/share. Meanwhile the lowest TVTX historical earnings result was in Q1 2022, when TVTX posted adjusted EPS of -0.820/share. Moving to Travere Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2021 when TVTX reported 0.07B in revenue, while the smallest revenue quarter was Q1 2014 when TVTX reported 30000 in revenue.

For self directed investors doing their due diligence on TVTX or any other given stock, their research can benefit from looking into all of the Travere Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Travere Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for TVTX. Thanks for visiting, and the next time you need to research TVTX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Institutional Holders of MAB, CELZ market cap history, Funds Holding CSML.

 

TVTX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.